Literature DB >> 202163

Mesectodermal leiomyosarcoma of the antrum and orbit.

F A Jakobiec, J P Mitchell, P M Chauhan, T Iwamoto.   

Abstract

A 39-year-old black man developed a left antral leiomyosarcoma that subsequently extended into the ipsilateral orbit. On light microscopic appearance of the antral tumor the presence of a distinctive myxoid and fibrillar cytoplasmic background suggested the diagnosis of a malignant Schwann's cell tumor. A second biopsy of the orbital extension displayed the same fibrillar character, but the emergence of tumor giant cells with cytoplasmic trichrome positivity also raised the possibility of a rhabdomyosarcoma. Electron microscopy demonstrated the smooth muscle derivation of the tumor, which probably originated from vascular smooth muscle elements. The atypical neural appearance of this myogenous tumor may have been caused by the extensive neural crest contribution to the cephalic connective tissues (mesectoderm). Radiation therapy and chemotherapy were ineffective.

Entities:  

Mesh:

Year:  1978        PMID: 202163     DOI: 10.1016/s0002-9394(14)76664-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Mesectodermal leiomyosarcoma of the ciliary body.

Authors:  Sun-Won Park; Hyung-Jin Kim; Hee-Seung Chin; Kee-Sun Tae; Jee-Young Han
Journal:  AJNR Am J Neuroradiol       Date:  2003-10       Impact factor: 3.825

2.  Orbital metastasis of retroperitoneal leiomyosarcoma.

Authors:  Juan Chen; Ruili Wei; Xiaoye Ma
Journal:  Med Oncol       Date:  2011-01-25       Impact factor: 3.064

Review 3.  Leiomyosarcoma of the Nasal Cavity and Paranasal Sinuses: A Case Report and Comprehensive Review of the Literature.

Authors:  Sumita S Sam; Brian Stewart; Elham Nasri; Marino E Leon; Ernesto Martinez Duarte
Journal:  Head Neck Pathol       Date:  2022-02-14

4.  Mesectodermal leiomyoma of the ciliary body: case report.

Authors:  V White; K Stevenson; A Garner; J Hungerford
Journal:  Br J Ophthalmol       Date:  1989-01       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.